Male Hair Advice
Male Hair Advice · Evidence Desk

Stopping Finasteride: What Actually Happens and How Fast

The DHT comes back in about two weeks. The hair follows in 6–12 months. Here's the honest timeline for finasteride discontinuation — and the step-down options that preserve some benefit.

Updated July 17, 2026 7 min read Reviewed against 2026 clinical literature

For various reasons — side effects, cost, pregnancy planning, or just wondering what happens — men stop finasteride. The question that follows is predictable: "how fast does the hair loss come back?" The answer is less catastrophic than many fear and more significant than some doctors communicate. Here's the honest picture.

01What finasteride actually does when you stop

Finasteride's DHT-suppressing effect resolves within about two weeks of stopping. Once DHT levels return to baseline, the follicles that were being protected from miniaturization resume their progression. The drug doesn't create a new baseline — it holds the one you had when you started. Stopping returns you to where you would have been without treatment.

The timeline data

Most men who stop finasteride after long-term use begin losing the gained or preserved hair within 6–12 months. Significant reversion toward pre-treatment baseline is typically visible by 12–18 months post-discontinuation. Years of drug-preserved hair density can be largely lost within two years of stopping.

02Why this matters for the "just try it" crowd

This is also why the "try it for a year and see" advice needs context: if you try it for a year, see good results, then stop — the results don't stay. The drug is maintenance, not a cure. Setting that expectation from the start prevents the all-too-common pattern of getting good results, stopping, losing them, and concluding "it didn't work long-term."

03The step-down option: topical finasteride

For men who want to reduce systemic DHT exposure — whether for side effects, fertility concerns, or other reasons — topical finasteride is a legitimate step-down. It provides scalp-level DHT suppression with roughly 100-fold lower plasma finasteride levels than the oral dose. Whether it matches oral finasteride's efficacy at individual scalp follicles is still being studied, but the pharmacokinetic argument for lower systemic impact is solid.

04Stopping for pregnancy planning

Finasteride is a Category X drug for pregnant women — the concern is with fetal exposure via handling or semen, not the patient. Men who are actively trying to conceive are often advised to stop or switch to topical forms. This is a specific conversation for a prescriber, not a blanket reason to stop — the actual transfer risk via semen is very low, but the prescriber conversation matters here.

The practical bottom line: finasteride is indefinite maintenance, like blood pressure medication for hypertension. If you stop, DHT comes back. If DHT comes back, the loss resumes. That's not a failure of the drug — it's how maintenance therapy works.

Considering a switch to topical?

Strut Health

Topical finasteride — lower systemic exposure
$125 offer

Compounded topical + oral finasteride and minoxidil formulas, prescriber included.

FDA notice: In February 2026 the FDA issued a Warning Letter to Strut Health regarding product labeling. Compounded topical finasteride also carries an April 2025 FDA safety alert. Discuss risks with the prescribing clinician before starting any compounded formula.
See Strut Health options

Care Bare Rx

Prescription consult to discuss options
$300 offer

Telehealth hair-loss intake with prescription minoxidil and finasteride options.

See Care Bare Rx options
Medical disclaimer. This article is for general education and is not medical advice. Hair-loss treatments carry individual risks and benefits — talk with a licensed clinician before starting, stopping, or combining any medication.

Affiliate disclosure. Male Hair Advice may earn a commission when you use the links marked “Paid link,” at no additional cost to you. We only include providers we believe are relevant to the topic, and commercial relationships never change our editorial assessments.